| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.052 | 0.8 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.045 | 0.8 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.041 | 0.8 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.038 | 0.8 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.051 | 0.8 |